BioSpace News Archive

Sprout Pharmaceuticals (Sprout) announced today that the U.S. Food and Drug Administration (FDA) has removed their contraindication, or ban, on alcohol use with Addyi® (flibanserin), the first-and-only approved non-hormonal pill for acquired, generalized HSDD in premenopausal women.

Tekni-Plex has purchased automation equipment solutions manufacturer MMC Packaging Equipment Ltd.

Vensana Capital today announced the closing of its inaugural fund, Vensana Capital I, with $225 million in committed capital.

The Merck Foundation (the Foundation) has launched HIV Care Connect, a $7 million, five-year initiative to help reduce disparities in access to care and improve health outcomes for persons with HIV living in vulnerable and underserved Southeastern U.S. communities.

EVA15 insufflator submission for FDA clearance planned for October 2019

Trellis Rx today announced a new partnership with Parkview Health, the largest healthcare provider in northeast Indiana and northwest Ohio

Inhibrx, Inc. (Inhibrx), a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates, announced today the enrollment of the first patient in a Phase 1 clinical trial of INBRX-101 (NCT03815396).

Locana, a leading RNA-targeting gene therapy company, today announced the appointment of Kathie M. Bishop, Ph.D. as chief scientific officer.

Resonetics announced today that it has acquired Tru Tech Systems, Inc. (“Tru Tech”), based in Michigan, a leading supplier of precision grinding services for the medical device market and CNC grinding equipment for the machine tool industry

Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products, today announced that Jesse Ledger, Nuvo’s President & Chief Executive Officer will present at the H.C. Wainwright 21st Annual Global Investment Conference to be held September 8-10, 2019